Importer of Controlled Substances Registration, 49579-49580 [2018-21354]
Download as PDF
<![CDATA[
49579
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices
as a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Methylphenidate .......
Levomethorphan ......
Levorphanol ..............
Thebaine ..................
Remifentanil .............
Tapentadol ...............
Drug
code
Schedule
II
II
II
II
II
II
[FR Doc. 2018–21348 Filed 10–1–18; 8:45 am]
The
companies listed below applied to be
registered as bulk manufacturers of
various basic classes of controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
schedule I and II controlled substances.
SUMMARY:
BILLING CODE 4410–09–P
1724
9210
9220
9333
9739
9780
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Notice of registration.
Company
FR docket
Published
American Radiolabeled Chem .................................................................................................................................
Cerilliant Corporation ...............................................................................................................................................
83 FR 28664
83 FR 28664
June 20, 2018.
June 20, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–21353 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
amozie on DSK3GDR082PROD with NOTICES1
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
Bulk Manufacturer of Controlled
Substances Application: Cambrex
Charles City
ACTION:
Controlled substance
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
VerDate Sep<11>2014
18:39 Oct 01, 2018
Jkt 247001
issuance of the proposed registration on
or before December 3, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June 8,
2018, Cambrex Charles City, 1205 11th
Street, Charles City, Iowa 50616 applied
to be registered as a bulk manufacturer
of the basic classes of controlled
substances:
Gamma Hydroxybutyric
Acid.
Amphetamine .................
Lisdexamfetamine ..........
Methylphenidate .............
4-Anilino-N-phenethyl-4piperidine (ANPP).
Phenylacetone ................
Cocaine ..........................
PO 00000
Frm 00050
Fmt 4703
Drug code
Drug code
Codeine ..........................
Oxycodone .....................
Hydromorphone ..............
Hydrocodone ..................
Morphine ........................
Oripavine ........................
Thebaine ........................
Opium extracts ...............
Opium fluid extract .........
Opium tincture ................
Opium, powdered ...........
Oxymorphone .................
Noroxymorphone ............
Fentanyl ..........................
9050
9143
9150
9193
9300
9330
9333
9610
9620
9630
9639
9652
9668
9801
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion to other controlled
substances and sale to its customers, for
dosage form development, for clinical
trials, and for use in stability
qualification studies.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–21351 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
Schedule
2010
I
1100
1205
1724
8333
II
II
II
II
8501
9041
II
II
Sfmt 4703
Controlled substance
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUMMARY:
E:\FR\FM\02OCN1.SGM
02OCN1
49580
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices
The
companies listed below applied to be
registered as importers of various basic
SUPPLEMENTARY INFORMATION:
classes of controlled substances.
Information on previously published
notices are listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
Company
FR Docket
AMRI Rensselaer, Inc .............................................................................................................................................
S&B Pharma, Inc ....................................................................................................................................................
Cerilliant Corporation ..............................................................................................................................................
Shertech Laboratories, LLC ....................................................................................................................................
Fresenius Kabi USA, LLC .......................................................................................................................................
VHG Labs DBA LGC Standards .............................................................................................................................
Catalent Pharma Solutions, LLC ............................................................................................................................
Fisher Clinical Services, Inc ....................................................................................................................................
Anderson Brecon, Inc .............................................................................................................................................
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971.
The DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–21354 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: R & D Systems, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 1, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 1, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearings must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearings
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
83
83
83
83
83
83
83
83
83
amozie on DSK3GDR082PROD with NOTICES1
Jkt 247001
PO 00000
Frm 00051
Fmt 4703
April 9, 2018.
July 5, 2018.
July 16, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
August 1, 2018.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
9, 2018, R & D Systems, Inc., 614
McKinley Place NE, Minneapolis,
Minnesota 55413–5541 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
17:16 Oct 01, 2018
15176
31421
32906
34879
34878
34875
34874
34879
37525
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
Controlled substance
VerDate Sep<11>2014
FR
FR
FR
FR
FR
FR
FR
FR
FR
Published
Sfmt 4703
E:\FR\FM\02OCN1.SGM
02OCN1
1248
7118
7297
7360
7370
7391
7405
7435
7438
2270
7471
9041
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
]]>Agencies
[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49579-49580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21354]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
[[Page 49580]]
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices are listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
AMRI Rensselaer, Inc.......... 83 FR 15176 April 9, 2018.
S&B Pharma, Inc............... 83 FR 31421 July 5, 2018.
Cerilliant Corporation........ 83 FR 32906 July 16, 2018.
Shertech Laboratories, LLC.... 83 FR 34879 July 23, 2018.
Fresenius Kabi USA, LLC....... 83 FR 34878 July 23, 2018.
VHG Labs DBA LGC Standards.... 83 FR 34875 July 23, 2018.
Catalent Pharma Solutions, LLC 83 FR 34874 July 23, 2018.
Fisher Clinical Services, Inc. 83 FR 34879 July 23, 2018.
Anderson Brecon, Inc.......... 83 FR 37525 August 1, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971.
The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-21354 Filed 10-1-18; 8:45 am]
BILLING CODE 4410-09-P
